Changes to Medicare Part D Call for a Reexamination of Creditable Coverage - Bim Group

Changes to Medicare Part D Call for a Reexamination of Creditable Coverage

READ TIME: 5 MINUTES

Every year, group health plans are required to notify their Medicare-eligible policyholders whether their prescription drug coverage is “creditable coverage.” Drug coverage is creditable if it is as good or better than the Medicare drug benefit. If a Medicare-eligible individual is not enrolled in creditable coverage, they may incur late enrollment fees for every month they are not enrolled in Medicare part D.

There are two primary notice requirements for entities that offer prescription drug coverage:

  1. Annual disclosure to Medicare-eligible individuals covered by the plan by no later than October 15 of each
  2. Annual reporting to the Centers for Medicare & Medicaid Services (CMS) of creditable coverage status of their prescription drug plan within 60 days prior to the beginning of the plan year (Nov. 1 for calendar year plans), 30 days of the termination of a prescription drug plan, or 30 days after any change in creditable coverage

Overview of Creditable Coverage Changes

The Inflation Reduction Act (IRA) made several changes to Medicare Part D, including capping out-of-pocket expenses at

$2,000 for individuals with Medicare Part D starting in 2025 (this cap is indexed for following years). This is a significant change compared to the out-of-pocket maximum of $8,000 for 2024. This shift, with the other changes made by the IRA, will make it more difficult to meet the creditable coverage criteria, particularly for high deductible health plans.

What About Non-Calendar Year Plans?

The new Medicare Part D benefits affect plans’ creditable coverage determinations for calendar year plans beginning in 2025. Determination of creditable coverage for non-calendar year plans is not required until the plan renews in 2025. For example, if a plan renews on June 1, 2025, creditable coverage tested against the 2025 Medicare Part D parameters is not required to be evaluated and reported to CMS until April 1, 2025.

Employer Action Items

  • Review your If you have not already reviewed your coverage prior to the October 15 notification deadline, do so as soon as possible. Calendar year plans should be testing against the 2025 parameters and non- calendar year plans should be testing against the 2024 parameters until its CMS reporting is required prior to its 2025 plan year (60 days before the start of the plan year).
  • Notify CMS of creditable coverage changes within 30 days of

This information has been prepared for UBA by Fisher & Phillips LLP. It is general information and provided for educational purposes only. It is not intended to provide legal advice. You should not act on this information without consulting legal counsel or other knowledgeable advisors.

Recent Insights

June 12, 2025
ERISA

Navigating State PBM Laws: Understanding ERISA Preemption and Compliance

READ TIME: 6 MINUTES Pharmacy benefit managers (PBMs) play a pivotal role in the U.S. healthcare system, managing prescription drug benefits on behalf of insurers and employer-sponsored health plans. However, rising concerns over PBM transparency, pricing practices, and reimbursement rates have led to an expanding patchwork of state-level legislation. For employers – especially those offering […]
Read more
June 12, 2025
News

Federal Agencies Announce Pause in Enforcement of 2024 Mental Health Parity Rule

READ TIME: 5 MINUTES On May 15, 2025, the U.S. Departments of Labor (DOL), Health and Human Services (HHS), and the Treasury (IRS) (collectively, “the Departments”) issued an anticipated nonenforcement policy regarding the 2024 Final Rule implementing the Mental Health Parity and Addiction Equity Act (MHPAEA). This follows a legal challenge to the 2024 Final […]
Read more
June 12, 2025
Compliance Alert

May 2025 Compliance Recap

In May, applicable large employers were focused on RxDC reporting, due in June, and the PCORI filing, due in July. The U.S. Departments of Labor, Health and Human Services, and the Treasury jointly announced a pause in enforcement of the 2024 Final Rule implementing the Mental Health Parity and Addiction Equity Act (MHPAEA), and a […]
Read more
May 20, 2025
News

FAQs about the Patient Centered Outcomes Research Institute (PCORI) Fee

The Patient-Centered Outcomes Research Institute (PCORI) fee initially applied from 2012 to 2019. However, in December 2019, the Further Consolidated Appropriations Act, 2020 extended the fee to 2029. The PCORI fee applies to all plans that provide medical coverage to employees. Medical coverage includes preferred provider (PPO) plans, health maintenance organization (HMO) plans, point-of-service (POS) […]
Read more